Obicetrapib-ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease. Lee SJ, Kim BK. Lancet 2025 May 5:S0140-6736(25)00827-X. doi: 10.1016/S0140-6736(25)00827.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee SJ, Kim BK. Obicetrapib-ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease. Lancet 2025 May 5:S0140-6736(25)00827-X. doi: 10.1016/S0140-6736(25)00827.
PMID: 40347968